Physician profile
Scott Schirber
NPI 1558575498
$1,657.45
in general payments reported to CMS, 2019-2025
16 companies · $1,064 in 2025
The $1,064 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $103 · 2021: $25.43 · 2022: $116 · 2023: $39.34 · 2024: $71.17 · 2025: $1,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $747 · Food and Beverage: $399 · Honoraria: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $747.22 |
| Food and Beverage | $399.41 |
| Honoraria | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,047.29 | 2019-2025 | Wavelight Refractive Suite, Clareon, Unity |
| Biotissue Holdings INC. | $117.22 | 2022-2023 | |
| Abbvie INC. | $66.09 | 2025 | |
| Dompe US, INC. | $55.16 | 2020 | |
| Allergan, INC. | $52.30 | 2019-2021 | |
| New World Medical,INC. | $50.45 | 2024 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Shire North American Group INC | $49.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.99 | 2022-2023 | |
| Ani Pharmaceuticals, INC. | $33.73 | 2025 | Iluvien |
| Glaukos Corporation | $30.77 | 2019 | |
| Rxsight INC | $27.78 | 2025 | Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb Americas INC. | $19.20 | 2025 | Xiidra |
| Tarsus Pharmaceuticals, INC. | $18.80 | 2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $18.35 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $13.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Schirber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.